Barclays Keeps Their Buy Rating on Bunge Global (BG)
Barclays analyst Benjamin Theurer maintained a Buy rating on Bunge Global (BG) with a $150 price target. Morgan Stanley also assigned a Buy rating with a $140 target. Bunge reported Q2 revenue of $24.04B and net profit of $678M, up from $12.77B and $354M last year. Insider sentiment is positive.
How this was made
The 30-second read
Why it matters
The reaffirmed Buy ratings and earnings beat may sustain current price levels with modest upside potential.
Market read
Limited trading relevance; the news is a recap of already‑public earnings and analyst opinions.
What to watch
Potential commodity price volatility and exposure to agricultural supply‑chain risks.
Background
The article recaps recent analyst coverage and Bunge Global's quarterly earnings, providing no new primary data.
Ticker impact
Barclays and Morgan Stanley maintain Buy ratings on Bunge Global (BG) with price targets of $150 and $140, respectively, after the company reported Q2 revenue of $24.04 bn and net profit of $678 m.
likely modest upside as the market prices in the buy ratings and earnings beat
Both firms reaffirm Buy stance and raise targets; earnings more than double YoY, indicating strong performance.
Market effects
Positive signal for the Consumer Defensive sector as a major agribusiness shows strong earnings growth.
U.S. agribusiness investors may see slight buying pressure.
Limited; primarily affects BG and peers in the food‑ingredients space.
Counterpoint
The buy ratings may already be priced in; any further upside could be limited.
Key entities
- analystBarclays
Maintains Buy rating on BG with $150 target.
- analystMorgan Stanley
Maintains Buy rating on BG with $140 target.
